BIO-GATE AG O.N. overview

EQS-News: Bio-Gate AG / Key word(s): Incoming Orders/Letter of Intent Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants 31.07.2023 / 17:01 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS INFORMATION Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants Nuremberg/Bremen, July 31, 2023 - Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual...

The exclusive distribution agreement includes 5 SKUs from Pura H&W’s evidence-based derma-cosmetics portfolio The products will be commercialized through Bio-Gate’s existing distribution channels with initial launches planned for Germany, Austria, and Switzerland in 2022 TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and...